Biodistribution and Pharmacokinetic Analysis of Paclitaxel and Ceramide Administered in Multifunctional Polymer-Blend Nanoparticles in Drug Resistant Breast Cancer Model
Open Access
- 11 July 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 5 (4), 516-526
- https://doi.org/10.1021/mp800030k
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxelBiomaterials, 2008
- Paclitaxel and ceramide co‐administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancerInternational Journal of Cancer, 2007
- Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluationInternational Journal of Pharmaceutics, 2007
- Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancerInternational Journal of Pharmaceutics, 2005
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Tamoxifen retards glycosphingolipid metabolism in human cancer cellsFEBS Letters, 1996
- Accumulation of Glucosylceramides in Multidrug-resistant Cancer CellsOnline Journal of Public Health Informatics, 1996
- Biodegradable Long-Circulating Polymeric NanospheresScience, 1994
- Mechanisms of Multidrug Resistance in Cancer TreatmentActa Oncologica, 1992
- Mechanism of multidrug resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988